What does DR. JOHAN VANDERMAESEN do?

DR. JOHAN VANDERMAESEN is a specialist medical practice in Lummen. Private Limited, started on 20 February 1996, 1 establishment.

What is the address of DR. JOHAN VANDERMAESEN?

The registered office of DR. JOHAN VANDERMAESEN is located at Dr. Vanderhoeydonckstraat 20, 3560 Lummen.

Is DR. JOHAN VANDERMAESEN still active?

Yes. According to the CBE (30 October 2026) DR. JOHAN VANDERMAESEN is active, legal situation “Normale toestand”, started on 20 February 1996.

Is DR. JOHAN VANDERMAESEN registered on Peppol?

Yes, DR. JOHAN VANDERMAESEN is registered on the Peppol network with ID 0208:0457334412.

What is the enterprise number of DR. JOHAN VANDERMAESEN?

The enterprise number of DR. JOHAN VANDERMAESEN is BE0457334412.

When was DR. JOHAN VANDERMAESEN founded?

DR. JOHAN VANDERMAESEN was founded on 20 February 1996.

Who are the directors of DR. JOHAN VANDERMAESEN?

According to the 2025 annual accounts, the directors of DR. JOHAN VANDERMAESEN are: Johan Vandermaesen.

Is DR. JOHAN VANDERMAESEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 February 1996; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. JOHAN VANDERMAESEN make in 2025?

DR. JOHAN VANDERMAESEN recorded a loss after taxes of € 25,930 in financial year 2025.

What is the revenue of DR. JOHAN VANDERMAESEN?

As a small company, DR. JOHAN VANDERMAESEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -14,367.

DR. JOHAN VANDERMAESEN (Private Limited) - Lummen

Dossier DR. JOHAN VANDERMAESEN, printed on 30 October 2026 from databakkes.be/en/0457334412/dr-johan-vandermaesen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. JOHAN VANDERMAESEN from Lummen, company number BE0457334412, closed financial year 2025 with a result of € -25,930 after tax. For that financial year DR. JOHAN VANDERMAESEN recorded a gross margin of € -14,367 and equity of € 562,254. Compared with financial year 2024, the result moved from € 2,905 to € -25,930. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.

What it is worth Healthy

€ 562,254

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -25,930

▼ still € 2,905 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 20,638

▼ 68% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 556,026.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 16,896

▼ 44% vs 2024

€ 8,672 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 3,065

▼ 47% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 97,094 Gross margin 2022: € 97,094 First fiscal year in the series	€ 171,468 Gross margin 2023: € 171,468 ▲ 77% vs 2022 (€ 97,094) Favourable step	€ 59,367 Gross margin 2024: € 59,367 ▼ 65% vs 2023 (€ 171,468) Unfavourable step	€ -14,367 Gross margin 2025: € -14,367 ▼ € 73,734 vs 2024 (€ 59,367) Unfavourable step	▼ € 73,734
Profit after taxes	€ 37,913 Profit after taxes 2022: € 37,913 First fiscal year in the series	€ 46,566 Profit after taxes 2023: € 46,566 ▲ 23% vs 2022 (€ 37,913) Favourable step	€ 2,905 Profit after taxes 2024: € 2,905 ▼ 94% vs 2023 (€ 46,566) Unfavourable step	€ -25,930 Profit after taxes 2025: € -25,930 ▼ € 28,835 vs 2024 (€ 2,905) Unfavourable step	▼ € 28,835
Equity	€ 538,713 Equity 2022: € 538,713 First fiscal year in the series	€ 585,279 Equity 2023: € 585,279 ▲ 9% vs 2022 (€ 538,713) Favourable step	€ 588,184 Equity 2024: € 588,184 Unchanged (€ 585,279) Favourable step	€ 562,254 Equity 2025: € 562,254 ▼ 4% vs 2024 (€ 588,184) Unfavourable step	▼ 4%
Total debts	€ 243,570 Total debts 2022: € 243,570 First fiscal year in the series	€ 194,847 Total debts 2023: € 194,847 ▼ 20% vs 2022 (€ 243,570) Favourable step	€ 118,500 Total debts 2024: € 118,500 ▼ 39% vs 2023 (€ 194,847) Favourable step	€ 83,646 Total debts 2025: € 83,646 ▼ 29% vs 2024 (€ 118,500) Favourable step	▼ 29%
Cash	€ 41,503 Cash 2022: € 41,503 First fiscal year in the series	€ 127,649 Cash 2023: € 127,649 ▲ 208% vs 2022 (€ 41,503) Favourable step	€ 63,791 Cash 2024: € 63,791 ▼ 50% vs 2023 (€ 127,649) Unfavourable step	€ 20,638 Cash 2025: € 20,638 ▼ 68% vs 2024 (€ 63,791) Unfavourable step	▼ 68%
Retained profit	€ 532,485 Retained profit 2022: € 532,485 First fiscal year in the series	€ 579,051 Retained profit 2023: € 579,051 ▲ 9% vs 2022 (€ 532,485) Favourable step	€ 581,956 Retained profit 2024: € 581,956 ▲ 1% vs 2023 (€ 579,051) Favourable step	€ 556,026 Retained profit 2025: € 556,026 ▼ 4% vs 2024 (€ 581,956) Unfavourable step	▼ 4%
Bank debt	€ 49,384 Bank debt 2022: € 49,384 First fiscal year in the series	€ 38,418 Bank debt 2023: € 38,418 ▼ 22% vs 2022 (€ 49,384) Favourable step	€ 30,339 Bank debt 2024: € 30,339 ▼ 21% vs 2023 (€ 38,418) Favourable step	€ 16,896 Bank debt 2025: € 16,896 ▼ 44% vs 2024 (€ 30,339) Favourable step	▼ 44%
Balance sheet total	€ 782,283 Balance sheet total 2022: € 782,283 First fiscal year in the series	€ 780,126 Balance sheet total 2023: € 780,126 Unchanged (€ 782,283) Unchanged	€ 706,684 Balance sheet total 2024: € 706,684 ▼ 9% vs 2023 (€ 780,126) Unchanged	€ 645,900 Balance sheet total 2025: € 645,900 ▼ 9% vs 2024 (€ 706,684) Unchanged	▼ 9%

Key figures of DR. JOHAN VANDERMAESEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. JOHAN VANDERMAESEN?

What happened at DR. JOHAN VANDERMAESEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 30, 2026 New annual accounts for financial year 2025: loss of € 25,930 (▼ € 28,835 vs 2024). Source: NBB ↗
Feb 20, 1996 New establishment in Lummen. KBO
1996 Johan Vandermaesen became a director. NBB
Feb 20, 1996 Start of the company according to the CBE. KBO

In short

From € 37,913 profit in 2022 to € 25,930 loss in 2025.

Paid € 49,111 in corporate taxes since 2022.

Best year ever: 2023, with € 46,566 profit.

Original PDFs at the National Bank ↗

Management

Johan Vandermaesen

DR. JOHAN VANDERMAESEN

HUMA-INVEST

Behind DR. JOHAN VANDERMAESEN is Johan Vandermaesen. Johan Vandermaesen is also behind HUMA-INVEST.

Directors

According to the 2025 annual accounts

Johan Vandermaesen

Director

Also active at: HUMA-INVEST

since 1996

Establishments

Establishment units

Physical locations of this company

Registered office

Dr. Vanderhoeydonckstraat 20

3560 Lummen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

DR. DIEBRECHT APPELEN

€ -623 gross margin · 2025

Groepspraktijk dermatologie Lummen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0457.334.412
VAT number: BE 0457.334.412
Registered office: Dr. Vanderhoeydonckstraat 20, 3560 Lummen
Names & denominations: DR. JOHAN VANDERMAESEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 February 1996
Peppol: Active · Active since 1 Jan 2001
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗